THE ERBIUM CHOKEPOINT - A SUSPENDED RARE-EARTH RISK INSIDE AI OPTICAL NETWORKS

Sep 03, 2026

∙ Paid

SEQH CAPITAL RESEARCH - TEAR SHEET
THE ERBIUM CHOKEPOINT - A SUSPENDED RARE-EARTH RISK INSIDE AI OPTICAL NETWORKS

WHAT THIS REPORT ARGUES

Erbium is a small but strategically important component of the AI networking stack because it is the active dopant inside erbium-doped fiber amplifiers, or EDFAs, which regenerate and boost optical signals across long-haul, metro, and data-center-interconnect networks.
SEQH’s central finding is that China’s erbium export-control regime is suspended, not resolved. The relevant control was paused before taking effect, but the legal authority remains in place and the current suspension is scheduled to expire on November 10, 2026.

Core thesis

China added erbium, ytterbium, thulium, holmium, and europium to its export-control list in October 2025, before suspending implementation one month later under a trade-truce framework.
The risk is therefore not that EDFAs are currently blocked from supply. The risk is that a future reactivation could introduce export licensing, customs delays, supply uncertainty, and a multi-quarter requalification problem across the optical networking chain.
The report’s key distinction is that this is not primarily a raw-material cost problem. It is a lead-time, licensing, and qualification problem for manufacturers and network customers.

Erbium-doped fiber amplifiers are foundational to modern optical networking because they allow telecom-wavelength light signals to be amplified without converting them into electrical signals first.
This makes EDFAs critical to the long-distance optical links that connect AI data centers, cloud campuses, metro networks, and broader internet infrastructure.
The physical amount of erbium in an EDFA is tiny, likely in the sub-microgram to low-microgram range based on the report’s illustrative calculation. That means a major rise in erbium price would have limited direct bill-of-materials impact.
But replacing or requalifying an optical-fiber supplier can take multiple quarters, while a China export license could take roughly 10 weeks in a best-case scenario and potentially 12 to 16 weeks in practice.

The report identifies what it calls a zero-producer problem outside China for commercial erbium separation.
The major non-China heavy-rare-earth projects currently focus on elements such as dysprosium, terbium, samarium, gadolinium, yttrium, lutetium, neodymium, and praseodymium.
Lynas, MP Materials, and Caremag are all expanding or developing non-China heavy-rare-earth capability, but none is disclosed as targeting commercial-scale erbium separation.
This means the optical industry has little visible Western redundancy for erbium specifically, even as supply-chain independence improves for other rare earths.

Lumentum has direct EDFA exposure through its optical-amplifier product portfolio, 980nm pump lasers, gain-flattening filters, and its own erbium-doped fiber product line.
Coherent also has direct EDFA exposure through its Nufern subsidiary, which manufactures erbium-doped and erbium/ytterbium co-doped specialty fiber in Connecticut.
Sivers Semiconductors is structurally insulated from this specific risk because its business centers on indium phosphide lasers, laser arrays, and semiconductor optical amplifiers rather than erbium-doped fiber.
Applied Optoelectronics also screens as insulated in the report’s filing review. Its CATV amplifiers are RF devices in the coaxial portion of a network and do not incorporate optical amplification or erbium-doped fiber.

The report’s most important research finding is that both Lumentum and Coherent appear to have real product-level erbium exposure, yet neither company’s most recent annual filing specifically names erbium in its rare-earth or critical-materials risk language.
Lumentum discloses generic risk from rare earth metals and other critical minerals, but does not quantify or identify its erbium-related supply exposure.
Coherent explicitly discusses its much larger and more visible indium phosphide exposure, including supply and licensing issues, while its Nufern erbium-doped-fiber exposure receives no similar discussion in reviewed filings or earnings calls.
SEQH does not claim this represents an intentional omission or proves material exposure. The report’s narrower conclusion is that the disclosure gap exists, and it may become relevant if the suspended controls return.

November 10, 2026 is the key date: the current expiration of China’s suspension of the erbium control regime.
Investors should watch for any Chinese announcement that extends, narrows, or permanently repeals the suspension.
Further movement in erbium oxide pricing is also relevant. The report cites a secondary-market reading near $82 per kilogram in August 2026, up about 17.6 percent month over month, though it cautions that the intra-year series is not primary-verified.
Another important signal would be any Lumentum or Coherent filing, earnings-call comment, or investor presentation that names erbium specifically. Such a disclosure could indicate that management considers the exposure material enough to discuss directly.
Finally, any Western company announcing commercial-scale erbium separation capacity would materially change the supply-chain thesis, because no such project is currently identified in the report.

The cleanest framing is that erbium is cheap, tiny, and easy to ignore until it is unavailable.
Lumentum and Coherent appear to have direct exposure through their EDFA and doped-fiber businesses, while Sivers and AAOI appear structurally insulated from the specific erbium chokepoint.
The relevant question is not whether erbium will suddenly make optical hardware expensive. It is whether a reactivated licensing regime can slow qualification, disrupt fiber availability, and create an unexpected bottleneck in the optical layer of the AI buildout.

What readers get in the full PDF
Upgrade to access the full report, including:

A complete China rare-earth export-control timeline, from the 2025 policy package through the November 2026 suspension-expiry date.
A detailed review of erbium’s role inside EDFAs, including the dosing chemistry, active-fiber structure, and why qualification time matters more than material cost.
The full non-China alternative-supply survey covering Lynas, MP Materials, Caremag, and the absence of commercial erbium separation plans.
Dedicated company deep dives on Lumentum, Coherent, Sivers, and AAOI, including product architecture, manufacturing locations, filing language, and material-risk disclosures.
The complete component-level exposure matrix showing erbium, EDFA, indium phosphide, manufacturing geography, and disclosure status across all four names.